Sanzyme BiologicsA-16Sanzyme Biologics® Offers ANVISA-Recognized, Branded Probiotic Strain: Bacillus coagulans SNZ 1969®
Bacillus coagulans SNZ 1969®, Sanzyme Biologics’ flagship strain, is supported by over 30 human clinical studies demonstrating benefits in digestive health, immunity, protein absorption, oral health, and women’s health, along with four studies in pets*. With over five decades of safe and effective use, SNZ 1969® is trusted by leading global brands.
In Brazil, Bacillus coagulans SNZ 1969® is included in ANVISA Normative Instruction (IN) No. 28/2018 and may be used as a constituent in conventional foods and food supplements, in accordance with ANVISA regulations. The strain is also notified under GRN No. 597 as GRAS in the U.S., holds Product License NPN No. 80093760 from Health Canada for use in adults and children, and has probiotic claims notified to FSANZ in Australia and New Zealand.
Sanzyme Biologics manufactures Bacillus coagulans in a dedicated NSF and FSSC 22000 certified facility, ensuring quality, safety, and compliance with global standards.
About Sanzyme Biologics
Sanzyme Biologics® is a pioneer in probiotics with over 50 years of expertise in fermentation. Established in 1969 as UniSankyo, it was the first company in India to manufacture and market probiotics and enzymes. Today, Sanzyme Biologics is a global player with a presence in over 45 countries.
Sanzyme Biologics develops and manufactures proprietary, clinically studied, branded probiotic strains for global markets. Its offerings cater to human health (food and supplements) and pet nutrition. Below are the probiotic strains and blends positioned for human and wellness applications:
• Bacillus coagulans SNZ 1969®
• Bacillus clausii SNZ 1971®
• Bacillus subtilis SNZ 1972®
• Saccharomyces boulardii™
• Patented and clinically studied probiotic blend SNZ TriBac®
Bacilli strains and SNZ TriBac® are shelf-stable, robust, and process-friendly, making them suitable for incorporation into various product formats such as functional foods, beverages, gummies, sachets, tablets, and capsules.
Bacillus clausii SNZ 1971® has been clinically studied in humans for digestive health*.
Sanzyme Biologics also offers PetGermina™, which has been clinically studied for digestive health benefits in pets*, including dogs of all sizes and various breeds, as well as cats.
Sanzyme Biologics manufactures its probiotic strains in a dedicated NSF and FSSC 22000 certified facility, ensuring consistent quality, safety, and compliance with global standards.
*Disclaimer: Regulatory requirements for probiotic use in foods, supplements, pet foods, and related products vary by country, region, and application. It is the responsibility of the manufacturer or marketer to ensure compliance with applicable regulations before commercialization.
